Literature DB >> 23095669

The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage.

Hiroji Yanamoto1, Hiroharu Kataoka, Yukako Nakajo, Koji Iihara.   

Abstract

Similar to atherosclerosis, platelet-derived growth factor (PDGF)-BB, a major growth factor for vascular smooth muscle cells, is produced in arterial walls to repair arteries after subarachnoid hemorrhage (SAH). On review of a series of research articles that focus on defensive host responses to SAH, PDGF-BB is identified as a spasmogen, based on the following findings: (1) foreign substances injected into the subarachnoid space cause persistent constriction of cerebral arteries with a time course and histological features almost identical to those seen after SAH; (2) persistent constriction induced by SAH or a foreign substance is dependent on the complement system; (3) the complement system, which stimulates platelets, macrophages and endothelial cells to secrete PDGF-BB, is activated in both the cerebrospinal fluid (CSF) and plasma immediately after SAH; (4) PDGF-BB levels in the CSF are significantly elevated in patients with delayed cerebral ischemia; (5) the immunodensity of PDGF-BB in the arterial walls correlates well with the severity of cerebral vasospasm; (6) intracisternal injection of PDGF-BB induces persistent constriction of cerebral arteries in a dose-dependent manner; (7) prolonged contact with blood clots promotes the contractile response of cerebral arteries to PDGF-BB, and (8) administration of an antagonist of PDGF-BB function suppresses the development of cerebral vasospasm.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095669     DOI: 10.1159/000341336

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

1.  Systematic model of peripheral inflammation after subarachnoid hemorrhage.

Authors:  Jude P J Savarraj; Kaushik Parsha; Georgene W Hergenroeder; Liang Zhu; Suhas S Bajgur; Sungho Ahn; Kiwon Lee; Tiffany Chang; Dong H Kim; Yin Liu; H Alex Choi
Journal:  Neurology       Date:  2017-03-17       Impact factor: 9.910

Review 2.  Cardiovascular complications in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

3.  Imatinib attenuates cerebrovascular injury and phenotypic transformation after intracerebral hemorrhage in rats.

Authors:  William J Pearce; Coleen Doan; Desirelys Carreon; Dahlim Kim; Lara M Durrant; Anatol Manaenko; Lauren McCoy; Andre Obenaus; John H Zhang; Jiping Tang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-05       Impact factor: 3.619

Review 4.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

Review 5.  Vasospasm in cerebral inflammation.

Authors:  Michael Eisenhut
Journal:  Int J Inflam       Date:  2014-12-29

6.  Alterations of caveolin-1 expression in a mouse model of delayed cerebral vasospasm following subarachnoid hemorrhage.

Authors:  Ye Xiong; Xue-Min Wang; Ming Zhong; Ze-Qun Li; Zhi Wang; Zuo-Fu Tian; Kuang Zheng; Xian-Xi Tan
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.